शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
IGCLNSEIndogulf Cropsciences Limited· Fertilizers & AgrochemicalsHighNeutral
Announced Wed, 11 Feb, 2026 · 18:23 IST

Indogulf Cropsciences Q3 FY26 results, director re-appointments approved

IGCL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-4.7%Reaction day
₹75.00
prior close
₹72.22
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.5%-4.2% vs market
Pesticides & Agrochemicals peers, median of 26sector-0.3%-4.5% vs sector

On the reaction day the stock moved 4.2 pts less than Nifty Microcap 250 and 4.5 pts less than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.4
10m
-0.3
15m
-2.1
30m
-1.8
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-4.7-0.5-4.2-0.3-4.5
Next day
-6.2-2.0-4.2-1.5-4.7
2d
-10.7-2.7-8.0-3.1-7.6
3d
-10.1-1.7-8.4-2.6-7.6
4d
-10.3-1.4-8.9-2.7-7.7
5d
-13.3-2.8-10.5-3.0-10.3
1w
-17.1-2.8-14.2-5.1-12.0
15d
-12.7-8.4-4.3-9.3-3.3
1m
-14.0-9.1-4.9-9.7-4.3
2m
-18.5-4.0-14.5-8.3-10.2
3m
-15.3+2.6-18.0-4.3-11.1
UpDownMarket · Nifty Microcap 250Sector · Pesticides & Agrochemicals peers, median of 26Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Indogulf Cropsciences reported Q3 FY26 (ended Dec 31, 2025) unaudited results with limited review carrying un-modified opinion. Standalone Q3 revenue rose to Rs 1,085.81M from Rs 983.68M YoY; 9M revenue at Rs 5,400.09M vs Rs 4,694.57M. Standalone Q3 PBT fell to Rs 73.37M from Rs 251M YoY. Consolidated 9M revenue at Rs 5,538.15M vs Rs 4,641.88M. Board re-appointed Executive Chairman and MD for 5 years from April 1, 2026, appointed new internal auditor, and approved a postal ballot notice.

Likely market impact

Revenue growing but profits down YoY. Director re-appointments signal leadership continuity and stability for shareholders.